Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Role of the Natural Killer (Nk) Cell Modulation in Breast Cancer Incidence and Progress Publisher Pubmed



Razeghian E1 ; Kameh MC2 ; Shafiee S3 ; Khalafi F3 ; Jafari F4, 5 ; Asghari M3 ; Kazemi K6 ; Ilkhani S7 ; Shariatzadeh S3 ; Hajmirzaian A8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Human Genetics Division, Medical Biotechnology Department, National Institute of Genetics Engineering and Biotechnology (NIGEB), Tehran, Iran
  2. 2. Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Department of Radiation Oncology, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Radiation Oncology Research Center, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University, Tehran, Iran
  8. 8. Department of Pharmacology, Tehran University of Medical Sciences, Tehran, Iran

Source: Molecular Biology Reports Published:2022


Abstract

The importance of the immune system on tumor surveillance has been investigated for many years, and its impact on controlling tumor progression has been verified. An important subgroup of the innate immune system is natural killer (NK) cells, whose essential function in modulating tumor behavior and suppressing metastasis and tumor growth has been demonstrated. The first idea of NK cells’ crucial biological processes was demonstrated through their potent ability to conduct direct cellular cytotoxicity, even without former sensitization. These properties of NK cells allow them to recognize transformed cells that have attenuated self-ligand and express stress-induced ligands. Furthermore, secretion of various cytokines and chemokines after their activation leads to tumor elimination via either direct cytotoxic effect on malignant cells or activation of the adaptive immune system. In addition, novel immunotherapeutic approaches tend to take advantage of NK cells’ ability, leading to antibody-based approaches, the formation of engineered CAR-NK cells, and adoptive cell transfer. However, the restricted functionality of NK cells and the inability to infiltrate tumors are its blind spots in breast cancer patients. In this review, we gathered newly acquired data on the biology and functions of NK cells in breast cancer and proposed ways to employ this knowledge for novel therapeutic approaches in cancers, particularly breast cancer. © 2022, The Author(s), under exclusive licence to Springer Nature B.V.
Other Related Docs
13. Car-Nk Cells for Haematological Cancers, Best Practice and Research: Clinical Haematology (2025)
16. Car-Nk Cells: A Promising Cellular Immunotherapy in Lymphoma, Expert Opinion on Biological Therapy (2023)
18. Antileukemia Activity of Human Natural Killer Cell-Derived Nanomagic Bullets Against Acute Myeloid Leukemia (Aml), International Journal of Hematology-Oncology and Stem Cell Research (2024)
21. Nk Cells - Dr. Jekyll and Mr. Hyde in Autoimmune Rheumatic Diseases, International Immunopharmacology (2022)
24. Tumor Immunology, Clinical Immunology (2022)
25. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
28. Genetically Modified Immune Cells Targeting Tumor Antigens, Pharmacology and Therapeutics (2020)
32. Immunopathology and Immunotherapy of Non-Hodgkin Lymphoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
38. Immunopathology and Immunotherapy of Non-Hodgkin Lymphoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
39. Immunopathology and Immunotherapy of Hodgkin Lymphoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
42. Breast Cancer Immunotherapy: Current and Novel Approaches, International Immunopharmacology (2021)
45. Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment, Regenerative Engineering and Translational Medicine (2024)